NCM · Medical - Equipment & Services

Park Dental Partners, Inc. (PARK) Stock

$19.85 -1.93% NCM: PARK Healthcare

Valuation

MetricValue
Price$19.85
Market Cap$94.39M
P/E Ratio-23.93
P/B Ratio3.04
P/S Ratio0.36
EPS (TTM)$-0.18
52-Week High$26.79
52-Week Low$9.53
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-18.26%
ROA-1.90%
ROCE-4.69%
Gross Margin0.10%
Operating Margin0.10%
Net Margin-1.41%
Debt/Equity2.02
Current Ratio1.06

Annual Financials (USD)

Metric202320242025
Revenue$224.0M$230.0M$244.0M
Operating Profit$2.0M$9.0M$3.0M
Net Profit$5.0M$4.0M$0
EPS$2.70$1.07$-0.08
Op Margin1.0%3.8%1.2%

Balance Sheet (USD)

Metric202320242025
Total Assets$155.0M$155.0M$197.0M
Total Liabilities$157.0M$159.0M$175.0M
Cash$1.0M$3.0M$25.2B
Borrowings$61.0M$62.0M$60.0M

Latest News

Park Dental Partners Announces Dates for Second Quarter 2026 Earnings Release and Conference Call GlobeNewswire · Jul 20, 2026 Park Dental Partners Expands Presence in Rochester, Minn., with Addition of Zumbro View Dental GlobeNewswire · Jun 4, 2026 Favourable Signals For Park Dental Partners: Numerous Insiders Acquired Stock Simply Wall St. · Jun 3, 2026 Here's What Could Help Park Dental Partners, Inc. (PARK) Maintain Its Recent Price Strength Zacks · Jun 2, 2026 Park Dental (PARK) Q1 2026 Earnings Transcript Motley Fool · May 19, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$13.0M$16.0M$18.0M
Investing Cash Flow$-23.0M$-14.0M$-18.0M
Financing Cash Flow$0$-1.0M$-1.0M
Net Cash Flow$1.0M$2.0M$23.0M
Free Cash Flow$4.0M$10.0M$10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.29
EV / EBITDA-327680.03
FCF Yield5547.16%
Quick Ratio1.12
Interest Coverage-9.35
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held22.00%
Institutions Held21.80%
Institutions Float Held27.95%
Institutional HolderSharesReport Date
Kennedy Capital Management, LLC241,2572026-03-31
Heartland Advisors Inc.189,5392026-03-31
Pacific Ridge Capital Partners, LLC135,5002026-03-31
Russell Investments Group, Ltd.97,4712026-03-31
Access Financial Services, Inc.49,6872026-06-30

About Park Dental Partners, Inc.

Park Dental Partners, Inc. is led by CEO Peter G. Swenson, employs 1,208 people, headquartered in US, publicly traded since 2018.

Park Dental Partners, Inc. (PARK) stock trades at $19.85 with a market capitalization of $94.39M. The stock is valued at a negative price-to-earnings (P/E) ratio of -23.93, reflecting a net loss over the last twelve months, price-to-book of 3.04, price-to-sales of 0.36. Over the past 52 weeks the stock has ranged between $9.53 and $26.79, and currently trades 25.9% below its 52-week high.

On profitability, Park Dental Partners, Inc. generates a return on equity (ROE) of -18.26% (negative, reflecting a net loss), return on capital employed of -4.69%, an operating margin of 0.10%, a net profit margin of -1.41%.

Park Dental Partners, Inc. by the numbers, 2023–2025

Between 2023 and 2025 Park Dental Partners, Inc. reported revenue of $224.0M rising to $244.0M, a change of +8.9% across 3 years. Compounded, revenue has grown —% a year over five years, —% over three, 6.1% over the last twelve months. Net profit fell to $0.

Operating margin went from 1.0% in 2023 to 1.2% in 2025, essentially unchanged. The most recent net margin is -1.41%. On a trailing twelve-month basis to Jun '26, revenue is $251.0M and net profit $-4.0M.

Borrowings held roughly flat from $61.0M to $60.0M, cash from operations was $18.0M in the latest year, positive in 3 of the last 3.

Return on equity has averaged -116.7% over five years, and was 0.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Park Dental Partners, Inc. (PARK) — frequently asked questions

What is Park Dental Partners, Inc. (PARK) stock price today?

Park Dental Partners, Inc. (PARK) is currently trading at $19.85, down 1.93% today.

What is PARK P/E ratio?

Park Dental Partners, Inc.'s P/E ratio is -23.93. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is PARK return on equity (ROE)?

Park Dental Partners, Inc.'s return on equity (ROE) is -18.26%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Park Dental Partners, Inc.'s market cap?

Park Dental Partners, Inc. has a market capitalization of $94.39M.

Does PARK pay a dividend?

Park Dental Partners, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does PARK carry?

Park Dental Partners, Inc. has a debt-to-equity ratio of 2.02. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is PARK's profit margin?

Park Dental Partners, Inc. reports a net profit margin of -1.41% — the share of revenue left after every cost, including tax and interest.

What sector is PARK in?

Park Dental Partners, Inc. is classified under Healthcare, in the Medical - Equipment & Services industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is PARK listed on?

Park Dental Partners, Inc. trades on NCM under the ticker PARK.

What is PARK's 52-week range?

Over the last year Park Dental Partners, Inc. has traded between $9.53 and $26.79.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens PARK currently matches

On the figures above, Park Dental Partners, Inc. passes the filters for 1 of our ready-made screens, among them Micro Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Micro Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.